Philadelphia
Novartis and the University of Pennsylvania Perelman School of Medicine celebrated the opening of the $27 million Center for Advanced Cellular Therapeutics in February of 2016 in Philadelphia. Accommodating the production of personalized cancer treatments using chimeric antigen receptor technology, the 30,000-sf facility features 23,610 sf of laboratory and cell therapy manufacturing space as well as a 6,300-sf cleanroom. Supported by $20 million in funding from Novartis, the project is sited atop the Jordan Medical Education Center and South Pavilion Extension on the Penn Medicine campus.
Source
